Puma biotechnology acquisition new arrivals
Puma biotechnology acquisition new arrivals
Puma biotechnology acquisition new arrivals
Puma biotechnology acquisition new arrivals
Puma biotechnology acquisition new arrivals
Puma biotechnology acquisition new arrivals

Puma biotechnology acquisition new arrivals

Puma biotechnology acquisition new arrivals, Puma Biotech punts near 300 million on Takeda discard The Pharmaletter new arrivals

$47.00

SKU: 759595

Colour
  • Puma Biotechnology Reports Third Quarter 2024 Financial Results BioSpace
  • Puma Biotechnology out licenses Nerlynx in Canada The Pharmaletter
  • 42KB 2001 null null null null null 9 3 2003 null SRwb7hyt9G 7MM
  • Puma Biotechnology out licenses Nerlynx in Canada The Pharmaletter
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus